Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.

October 9, 2015October 9, 2015

Scleroderma Foundation Honors Genentech’s Dr. Jeffrey Siegel with Spirit of Leadership Award

News

This week at the Scleroderma Foundation of Southern California’s 17th annual “Key to a Cure” gala, Genentech‘s Senior Group Medical Director of Immunology, Dr. Jeffrey Siegel, will receive the honor ... Read more

September 18, 2015September 18, 2015

RayVa Topical Treatment Safe and Effective in Phase 2a SCL-Related Raynaud’s Phenomenon Trial from Apricus

News

Top-line results from the Apricus Biosciences, Inc. Phase 2a clinical trial for RayVa™ topical treatment in patients with scleroderma-related Raynaud’s phenomenon indicate the treatment is safe and effective. Patients tolerated ... Read more

September 16, 2015September 16, 2015

Initial Results for Phase 2 Bardoxolone Methyl Study For PAH to be Presented in October

News

Preliminary results for the Phase 2 LARIAT clinical trial conducted by Reata Pharmaceuticals for bardoxolone methyl in pulmonary arterial hypertension will be presented at the upcoming 2015 American College of ... Read more

August 17, 2015August 18, 2015

Study Finds Cell Microparticles Correlated with Lung Function in SSc Patients

News

Tiny pieces of damaged endothelial cells, aptly called “microparticles” due to their size, can be generated in patients with systemic sclerosis (SSc). These cell particulates are created from a variety of ... Read more

July 20, 2015July 20, 2015

New Collaboration Aims to Translate Anti-Fibrotic Therapies From Bench to Bedside

News

A collaboration between Bristol-Myers Squibb Company and The Medical University of South Carolina (MUSC) will focus on translational research for developing scleroderma and other fibrotic disease treatments. The goal is ... Read more

July 7, 2015July 7, 2015

Genentech’s Esbriet Safe and Tolerated By SSc-IPF Patients According To New Study

News

Patients in the LOTUSS study who were treated for systemic sclerosis-associated idiopathic pulmonary fibrosis (SSc-IPF) using Esbriet (pirfenidone) showed signs of drug tolerability, according to a presentation at the European League ... Read more

July 1, 2015July 1, 2015

Study Discusses Three Therapies for Digital Ulcers in SSc

News

Digital ulcers, or open sores on the fingers and toes that do not heal, are common complications of systemic sclerosis. Approximately 30% of patients with systemic sclerosis have digital ulcers, ... Read more

June 22, 2015June 22, 2015

Antiphospholipid Antibody Levels High In SSc Patients

News

Autoimmune conditions can sometimes come in pairs, and it appears that individuals for systemic sclerosis (SSc) may also be at a risk for antiphospholipid antibody syndrome. A study from the ... Read more

June 11, 2015June 11, 2015

Breakthrough Therapy Designation Awarded to Roche for SSc Treatment

News

It’s a breakthrough: Roche has been awarded breakthrough therapy designation status for its ACTEMRA®/RoACTEMRA® (tocilizumab) treatment in patients with systemic sclerosis. The designation will enable Roche to speed up development ... Read more

June 3, 2015June 3, 2015

Lung Reduction Surgery Conducted in India for the First Time on Scleroderma Patient

News

An expert surgical team conducted the first lung reduction surgery in India. The recipient of the new, size-reduced lung was a 30-year-old woman named Mrs. Anita Devi, who suffers from ... Read more